trending Market Intelligence /marketintelligence/en/news-insights/trending/y0RrYAM76-vHWt3fbCqogw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CTI BioPharma adds Syndax COO to board

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


CTI BioPharma adds Syndax COO to board

CTI BioPharma Corp. appointed Michael Metzger as a board member.

Metzger is currently president and COO of Syndax Pharmaceuticals Inc.